|
Morningstar•December 20, 2022
Pfizer Inc.: Pfizer Highlights Pipeline to Address Post-2025 Patent Cliff, as Long-Term Growth Concerns Linger
Symbols
Sector(s)
Healthcare
Rating
Current Price
$51.36
Fair Value
$48.00
Economic Moat
Wide
Stewardship
Standard
Company SummaryPfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
Analyst Note
by Damien Conover
*Updated on Dec 12, 2022
Business Strategy and Outlook
by Damien Conover
*Updated on Dec 12, 2022
Economic Moat
by Damien Conover
*Updated on Dec 12, 2022
Fair Value and Profit Drivers
by Damien Conover
*Updated on Dec 12, 2022
Risk and Uncertainty
by Damien Conover
*Updated on Dec 12, 2022
Stewardship
by Damien Conover
*Updated on Dec 12, 2022
Quotes from this report
Add to Portfolio
SymbolNamePriceIndustryCurrencyMarket CapMorningstar RatingEconomic MoatUncertainty RatingFair ValueLast Close Price/Fair Value
PFE | Pfizer, Inc. | 51.36 | Drug | USD | 288.3B | Wide | Medium | 48.00 | 107.00% | |
INNV | InnovAge Holding Corp. | 6.75 | Medical | USD | 915.097M | N/A | N/A | N/A | N/A | N/A |
RUBY | Rubius Therapeutics, Inc. | 0.1452 | Biotechnology | USD | 13.122M | N/A | N/A | N/A | N/A | N/A |
ABT | Abbott Laboratories | 106.59 | Medical | USD | 185.847B | Narrow | Medium | 104.00 | 102.49% | |
VAXX | Vaxxinity, Inc. | 1.4700 | Biotechnology | USD | 185.302M | N/A | N/A | N/A | N/A | N/A |
NVS | Novartis AG | 90.19 | Drug | USD | 194.671B | Wide | Low | 90.00 | 100.21% | |
BMRN | BioMarin Pharmaceutical Inc. | 106.61 | Biotechnology | USD | 19.813B | Narrow | Medium | 105.00 | 101.53% | |
OMGA | Omega Therapeutics, Inc. | 5.25 | Biotechnology | USD | 252.257M | N/A | N/A | N/A | N/A | N/A |
VNDA | Vanda Pharmaceuticals Inc. | 7.21 | Biotechnology | USD | 408.014M | N/A | N/A | N/A | N/A | N/A |
GOSS | Gossamer Bio, Inc. | 2.0300 | Biotechnology | USD | 191.788M | N/A | N/A | N/A | N/A | N/A |
SRPT | Sarepta Therapeutics, Inc. | 123.00 | Biotechnology | USD | 10.797B | N/A | N/A | N/A | N/A | N/A |
IDRA | Idera Pharmaceuticals, Inc. | 0.2600 | Biotechnology | USD | 16.212M | N/A | N/A | N/A | N/A | N/A |
TVTX | Travere Therapeutics, Inc. | 19.32 | Biotechnology | USD | 1.24B | N/A | N/A | N/A | N/A | N/A |
JNJ | Johnson & Johnson | 175.48 | Drug | USD | 458.789B | Wide | Low | 164.00 | 107.00% | |
MGNX | MacroGenics, Inc. | 5.82 | Biotechnology | USD | 357.786M | N/A | N/A | N/A | N/A | N/A |
JANX | Janux Therapeutics, Inc. | 11.10 | Biotechnology | USD | 462.459M | N/A | N/A | N/A | N/A | N/A |
SNYNF | SANOFI | 93.44 | Drug | USD | 121.892B | N/A | N/A | N/A | N/A | N/A |
AZN | Astrazeneca PLC | 67.47 | Drug | USD | 217.081B | Wide | Medium | 74.00 | 91.18% | |
INVA | Innoviva, Inc. | 12.76 | Biotechnology | USD | 890.434M | N/A | N/A | N/A | N/A | N/A |
ESPR | Esperion Therapeutics, Inc. | 5.90 | Drug | USD | 434.733M | N/A | N/A | N/A | N/A | N/A |
NEOG | Neogen Corporation | 14.64 | Diagnostics | USD | 3.164B | Narrow | Medium | 26.00 | 56.31% | |
NXGL | NexGel, Inc | 1.5800 | Medical | USD | 8.804M | N/A | N/A | N/A | N/A | N/A |
PRGO | Perrigo Company plc | 31.12 | Drug | USD | 4.19B | underreview | None | Medium | 47.50 | 65.52% |
CORT | Corcept Therapeutics Incorporat | 20.30 | Biotechnology | USD | 2.185B | N/A | N/A | N/A | N/A | N/A |
TEVA | Teva Pharmaceutical Industries | 8.57 | Drug | USD | 10.171B | underreview | None | Extreme | 10.00 | 85.70% |
DAWN | Day One Biopharmaceuticals, Inc | 19.80 | Biotechnology | USD | 1.456B | N/A | N/A | N/A | N/A | N/A |
MRTX | Mirati Therapeutics, Inc. | 41.43 | Biotechnology | USD | 2.386B | N/A | N/A | N/A | N/A | N/A |
TNGX | Tango Therapeutics, Inc. | 7.75 | Biotechnology | USD | 683.375M | N/A | N/A | N/A | N/A | N/A |
QURE | uniQure N.V. | 21.95 | Biotechnology | USD | 1.028B | N/A | N/A | N/A | N/A | N/A |
VRTX | Vertex Pharmaceuticals Incorpor | 291.59 | Biotechnology | USD | 74.849B | Narrow | High | 306.00 | 95.29% | |
RETA | Reata Pharmaceuticals, Inc. | 36.43 | Biotechnology | USD | 1.335B | N/A | N/A | N/A | N/A | N/A |
SRRK | Scholar Rock Holding Corporatio | 7.83 | Biotechnology | USD | 404.524M | N/A | N/A | N/A | N/A | N/A |
RCKT | Rocket Pharmaceuticals, Inc. | 21.00 | Biotechnology | USD | 1.653B | N/A | N/A | N/A | N/A | N/A |
VTRS | Viatris Inc. | 10.91 | Drug | USD | 13.23B | underreview | None | Very High | 12.50 | 87.28% |
NVAX | Novavax, Inc. | 10.32 | Biotechnology | USD | 810.161M | N/A | N/A | N/A | N/A | N/A |
BLCO | Bausch + Lomb Corporation | 14.75 | Medical | USD | 5.163B | Narrow | Medium | 25.00 | 59.00% | |
BAYRY | BAYER AG SPON ADR EACH REP 0.25 | 12.92 | Drug | USD | 52.905B | Wide | Medium | 20.00 | 64.60% | |
IONS | Ionis Pharmaceuticals, Inc. | 37.96 | Biotechnology | USD | 5.392B | Narrow | High | 62.00 | 61.23% | |
VKTX | Viking Therapeutics, Inc. | 6.99 | Biotechnology | USD | 536.053M | N/A | N/A | N/A | N/A | N/A |
ABBV | AbbVie Inc. | 161.49 | Drug | USD | 285.592B | Narrow | High | 120.00 | 134.58% | |
CDMO | Avid Bioservices, Inc. | 13.14 | Biotechnology | USD | 818.746M | N/A | N/A | N/A | N/A | N/A |
CADL | Candel Therapeutics, Inc. | 1.6500 | Biotechnology | USD | 47.675M | N/A | N/A | N/A | N/A | N/A |
SVRA | Savara, Inc. | 1.4700 | Biotechnology | USD | 167.645M | N/A | N/A | N/A | N/A | N/A |
SNY | Sanofi | 46.98 | Drug | USD | 120.34B | Wide | Medium | 57.00 | 82.42% | |
BMY | Bristol-Myers Squibb Company | 73.16 | Drug | USD | 155.55B | Wide | Medium | 66.00 | 110.85% | |
GILD | Gilead Sciences, Inc. | 86.42 | Drug | USD | 108.391B | Wide | Medium | 77.00 | 112.23% | |
VTYX | Ventyx Biosciences, Inc. | 31.84 | Biotechnology | USD | 1.803B | N/A | N/A | N/A | N/A | N/A |
JNCE | Jounce Therapeutics, Inc. | 0.7208 | Biotechnology | USD | 37.261M | N/A | N/A | N/A | N/A | N/A |
RCUS | Arcus Biosciences, Inc. | 30.51 | Biotechnology | USD | 2.209B | N/A | N/A | N/A | N/A | N/A |
CTLT | Catalent, Inc. | 43.88 | Drug | USD | 7.897B | Narrow | Medium | 82.00 | 53.51% | |
LGND | Ligand Pharmaceuticals Incorpor | 65.08 | Biotechnology | USD | 1.099B | N/A | N/A | N/A | N/A | N/A |
SGEN | Seagen Inc. | 127.63 | Biotechnology | USD | 23.696B | Narrow | High | 150.00 | 85.09% | |
BHC | Bausch Health Companies Inc. | 7.00 | Drug | USD | 2.533B | underreview | None | Very High | 29.00 | 24.14% |
BPMC | Blueprint Medicines Corporation | 42.97 | Biotechnology | USD | 2.571B | N/A | N/A | N/A | N/A | N/A |
ABIO | ARCA biopharma, Inc. | 2.4000 | Biotechnology | USD | 34.584M | N/A | N/A | N/A | N/A | N/A |
INCY | Incyte Corporation | 80.59 | Biotechnology | USD | 17.929B | Narrow | High | 105.00 | 76.75% | |
DGX | Quest Diagnostics Incorporated | 151.45 | Diagnostics | USD | 17.248B | Narrow | Medium | 143.00 | 105.91% | |
TRDA | Entrada Therapeutics, Inc. | 19.89 | Biotechnology | USD | 624.669M | N/A | N/A | N/A | N/A | N/A |
LLY | Eli Lilly and Company | 357.78 | Drug | USD | 339.955B | Wide | Medium | 273.00 | 131.05% | |
INFI | Infinity Pharmaceuticals, Inc. | 0.4851 | Biotechnology | USD | 43.342M | N/A | N/A | N/A | N/A | N/A |
CVM | Cel-Sci Corporation | 2.1100 | Biotechnology | USD | 91.505M | N/A | N/A | N/A | N/A | N/A |
HOOK | HOOKIPA Pharma Inc. | 0.7803 | Biotechnology | USD | 42.695M | N/A | N/A | N/A | N/A | N/A |
BAX | Baxter International Inc. | 49.95 | Medical | USD | 25.181B | Narrow | Medium | 85.00 | 58.76% | |
SELB | Selecta Biosciences, Inc. | 1.1000 | Biotechnology | USD | 168.334M | N/A | N/A | N/A | N/A | N/A |
REGN | Regeneron Pharmaceuticals, Inc. | 721.10 | Biotechnology | USD | 78.529B | Narrow | Medium | 690.00 | 104.51% | |
AMRX | Amneal Pharmaceuticals, Inc. | 2.1600 | Drug | USD | 655.761M | N/A | N/A | N/A | N/A | N/A |
GSK | GSK plc | 34.87 | Drug | USD | 73.523B | Wide | Medium | 50.00 | 69.74% | |
RHHBY | ROCHE HOLDINGS AG SPN ADR EACH | 40.15 | Drug | USD | 266.632B | Wide | Low | 57.00 | 70.44% | |
BAYZF | BAYER AG | 52.08 | Drug | USD | 53.285B | N/A | N/A | N/A | N/A | N/A |
TMDX | TransMedics Group, Inc. | 55.43 | Medical | USD | 1.77B | N/A | N/A | N/A | N/A | N/A |
HCWB | HCW Biologics Inc. | 2.0300 | Biotechnology | USD | 72.819M | N/A | N/A | N/A | N/A | N/A |
RHHVF | ROCHE HOLDINGS AG | 320.90 | Drug | USD | 267.087B | N/A | N/A | N/A | N/A | N/A |
SNDX | Syndax Pharmaceuticals, Inc. | 23.37 | Biotechnology | USD | 1.592B | N/A | N/A | N/A | N/A | N/A |
AVRO | AVROBIO, Inc. | 0.7713 | Biotechnology | USD | 33.763M | N/A | N/A | N/A | N/A | N/A |
GLYC | GlycoMimetics, Inc. | 2.2000 | Biotechnology | USD | 115.333M | N/A | N/A | N/A | N/A | N/A |
KPTI | Karyopharm Therapeutics Inc. | 2.9700 | Biotechnology | USD | 241.03M | N/A | N/A | N/A | N/A | N/A |
CUE | Cue Biopharma, Inc. | 2.6800 | Biotechnology | USD | 115.354M | N/A | N/A | N/A | N/A | N/A |
CYT | Cyteir Therapeutics, Inc. | 1.2000 | Biotechnology | USD | 42.527M | N/A | N/A | N/A | N/A | N/A |
MRK | Merck & Company, Inc. | 109.44 | Drug | USD | 277.474B | Wide | Medium | 97.00 | 112.82% | |
IPSC | Century Therapeutics, Inc. | 6.97 | Biotechnology | USD | 411.05M | N/A | N/A | N/A | N/A | N/A |
SAVA | Cassava Sciences, Inc. | 38.10 | Biotechnology | USD | 1.59B | N/A | N/A | N/A | N/A | N/A |
MTEM | Molecular Templates, Inc. | 0.3699 | Biotechnology | USD | 20.844M | N/A | N/A | N/A | N/A | N/A |
NGM | NGM Biopharmaceuticals, Inc. | 4.8600 | Biotechnology | USD | 397.189M | N/A | N/A | N/A | N/A | N/A |
CRL | Charles River Laboratories Inte | 216.53 | Diagnostics | USD | 11.017B | Narrow | Medium | 260.00 | 83.28% | |
TCRT | Alaunos Therapeutics, Inc. | 0.5445 | Biotechnology | USD | 130.904M | N/A | N/A | N/A | N/A | N/A |
UTHR | United Therapeutics Corporation | 271.65 | Biotechnology | USD | 12.381B | None | High | 213.00 | 127.54% | |
CHD | Church & Dwight Company, Inc. | 79.89 | Household | USD | 19.483B | None | Medium | 58.00 | 137.74% | |
EBS | Emergent Biosolutions, Inc. | 11.16 | Drug | USD | 556.752M | N/A | N/A | N/A | N/A | N/A |
BIIB | Biogen Inc. | 284.38 | Drug | USD | 40.951B | Wide | High | 330.00 | 86.18% |
|